#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Emphysema Stiff person syndrome Fungal infection Dupuytren's contracture Turner's syndrome Kearns-Sayre syndrome Hepatitis B Warm autoimmune haemolytic anaemia Anti-HLA antibody test positive Angelman's syndrome Philadelphia chromosome positive Mantle cell lymphoma Burkitt's lymphoma Malignant oligodendroglioma Lymphangioma More trials…

    Learn about Rare Diseases

    Atypical haemolytic uraemic syndrome – Treatment Sarcoidosis – Life with Disease Congenital hypotransferrinaemia – Treatment Crigler-Najjar syndrome – Basic Information Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Systemic sclerosis pulmonary Marfan’s syndrome – Trials in Disease Hereditary angioedema with C1 esterase inhibitor deficiency Mantle cell lymphoma stage II – Life with Disease Castleman’s disease – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Romosozumab Dolutegravir Sodium Neob Nirogacestat Hydrobromide Interleukin-1 MZE829 GSKVX000000048111 Seladelpar Surzebiclimab Setrusumab Ripretinib Cldn6 Rna-Lpx Goserelin Acetate NORELGESTROMIN Skin Autograft Zalunfiban Ly4100511 Cart45Ra-Nkg2D Cells Ziltivekimab Mezigdomide More therapies…

    Learn about Your Condition

    Anal abscess Hypogonadism male Monkeypox Cutaneous T-cell lymphoma Immune thrombocytopenia Epidermolysis bullosa Von Willebrand's disease Carpal tunnel syndrome Lung adenocarcinoma stage III Small for dates baby Neuromyopathy Hypoalbuminaemia Dedifferentiated liposarcoma Bone sarcoma Substance use disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Diagnosis

  • Study on PET/CT Imaging with [18F]-AlF-FAPI-74 for Identifying Fibrosis and Inflammation in Patients with Progressive Pulmonary Fibrosis

    Recruiting

    1 1 1
    Investigated Drugs:
    • [Al[18F]F]Fapi-74
    The Netherlands

  • Study of Brain Injury and Concussion Symptoms Using Tau Tracer [18F]RO6958948 in Patients with Traumatic Brain Injury and Hemorrhages

    Recruiting

    2 1 1
    Investigated Diseases:
    • Brain injury
    Investigated Drugs:
    • 2-(6-[18F]Fluoro-Pyridin-3-Yl)-9H-Dipyrido[2,3-B:3′,4′-D]Pyrrole
    Sweden

  • Study Comparing [18F]meta-fluorobenzylguanidine PET-CT and Iodine (123I) Iobenguane Scans for Detecting Neuroblastoma in Patients

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Neuroblastoma
    Investigated Drugs:
    • Iodine (123I) Iobenguane
    • [18F]Meta-Fluorobenzylguanidine
    The Netherlands

  • Title: Evaluation of Gallium-68 FAPI-46 PET Imaging for Better Detection and Monitoring of Pancreatic Cancer and Bile Duct Cancer

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Cholangiocarcinoma
    • Pancreatic carcinoma
    Investigated Drugs:
    • Gallium (68Ga) Chloride
    The Netherlands

  • Study on the Use of 68Ga-FAPI-46 and Fludeoxyglucose (18F) for Diagnosing Pleural Mesothelioma in Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Pleural mesothelioma
    Investigated Drugs:
    • Fludeoxyglucose (18F)
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    Denmark

  • Study of Intra-Arterial Infusion of Lutetium (177Lu) Oxodotreotide for Adults with Gastroenteropancreatic Neuroendocrine Tumors with Liver Metastases

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Gastroenteropancreatic neuroendocrine tumour disease
    Investigated Drugs:
    • Amlodipine Besilate
    • Arginine Hydrochloride
    • Edotreotide
    France
Previous Page
1 … 4 5 6 7 8 … 22
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!